Hydrocortisonum Ziaja (Hydrocortisone Acetate)

Hydrocortisonum Ziaja is commonly used for the topical treatment of several mild to moderate inflammatory skin disorders.

• Eczema (atopic dermatitis), helping to reduce redness, itching and scaling.
• Contact dermatitis caused by allergens or irritants, providing relief from inflammation.
• Mild plaque psoriasis, assisting in decreasing plaque thickness and discomfort.
• Seborrheic dermatitis of the scalp or face, soothing flaking and erythema.
• General inflammatory rash or minor skin irritation, supporting faster symptom resolution.
• Lichen simplex chronicus, reducing chronic itching and thickened skin.
• Pruritic skin conditions associated with minor burns or abrasions, helping to calm inflammation.

• Hydrocortisonum Ziaja delivers hydrocortisone acetate to the epidermis, where the compound penetrates keratinocytes and binds intracellular glucocorticoid receptors. The receptor‑ligand complex translocates to the nucleus and interacts with glucocorticoid response elements, modulating gene transcription. This results in decreased synthesis of pro‑inflammatory cytokines, prostaglandins, and leukotrienes, while also inhibiting phospholipase A2 activity, leading to reduced edema, erythema and cellular infiltration in the treated area.

Topical hydrocortisone acetate may cause local or systemic adverse reactions, although many users experience no problems.

Common

• Skin irritation or burning sensation at the application site.
• Mild itching or dryness.
• Slight redness or folliculitis.
• Acneiform eruptions.
• Temporary thinning of the superficial skin layer with prolonged use.
• Mild swelling or edema around the treated area.
• Transient discoloration or hyperpigmentation of the skin.

Serious

• Contact dermatitis or allergic reaction with swelling and intense itching.
• Development of striae (stretch marks) on treated skin.
• Suppression of the hypothalamic‑pituitary‑adrenal axis with extensive application.
• Secondary bacterial, fungal or viral skin infection.
• Delayed wound healing or ulceration.

When using Hydrocortisonum Ziaja, certain precautions help minimize risks and ensure safe application.

• Avoid applying to broken, infected, or ulcerated skin unless directed by a healthcare professional.
• Do not use under occlusive dressings unless specifically advised, as this can increase systemic absorption.
• Limit treatment duration, typically not exceeding two weeks for the same area, to reduce skin atrophy.
• Use the smallest effective amount (the fingertip unit) to achieve symptom control.
• Discontinue use and seek medical advice if signs of allergic reaction or worsening skin condition appear.
• Caution in children, pregnant or breastfeeding individuals; consult a clinician before use.
• Avoid use on large body surface areas without supervision.

Hydrocortisonum Ziaja may interact with other topical agents or systemic medications that affect corticosteroid metabolism or skin integrity.

Avoid

• Concurrent use with potent topical steroids on the same area, which can increase risk of skin atrophy.
• Application together with topical calcineurin inhibitors without a washout period, as overlapping immunosuppression may occur.

Use with caution

• Systemic corticosteroids, because additive systemic effects may enhance hypothalamic‑pituitary‑adrenal suppression.
• Antifungal or antibacterial creams, since altered skin barrier can affect absorption.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically, which may increase local irritation.
• Phototherapy or UV exposure, as corticosteroids can increase photosensitivity.